Novartis is developing innovative medicines in a variety of disease categories and developing new technological platforms, cell and gene therapies, and radioligand therapeutics. Novartis is dedicated to developing and delivering access to gene treatments to patients and families affected by rare and life-threatening genetic illnesses. Rather than simply managing symptoms, cell and gene therapies are designed to stop or reverse disease progression.

Rabab Zehra, Executive Editor of TECHx Media, sat down with Sid Bhatia, Regional Vice President – Middle East & Turkey at Dataiku for a Special Feature on ‘Bridging The Gap Between Technology And Business,’ to learn more about the role Dataiku plays in empowering businesses during the ongoing wave of digital transformation.

The Programme will also launch 3 digital libraries in collaboration with Amazon, Huawei, and IBM, to give undergraduates in the UAE the opportunity to learn how to use various programming applications and apply them practically.

In 2021, organizations will take their MLOps foundations and go a step further to implement detailed processes and requirements around drift monitoring using MLOps. Input drift is based on the principle that a model is only going to predict accurately if the data it was trained on is an accurate reflection of the real world.

The solution enables IT teams to automate the collection, analysis, and remediation of performance issues in real-time using data observed from the very devices that are being impacted, as simulated or historical data simply cannot provide the same level of accuracy as live data.